A recent study has provided the first side-by-side comparison of how three major COVID-19 vaccine types differ in triggering ...

A study by Epi-Phare published on Thursday addresses misinformation surrounding vaccines that have been widely distributed ...

In their NEJM commentary, the former FDA heads stated, “We are deeply concerned by sweeping new FDA assertions about vaccine safety and proposals that would undermine a regulatory model designed to ...

BETHESDA, Md. - The National Institutes of Health announced on April 23, that it is launching a study to assess how people with compromised immune systems respond to COVID-19 vaccines. The study has ...

The head of the Food and Drug Administration's vaccine division claimed in a leaked email that “at least 10 children" died ...

AstraZeneca and Oxford University announced on Monday that they had developed a new Covid-19 vaccine with an efficacy rate of 70 to 90 percent. Trials indicated the vaccine could prevent 70 percent of ...

The results of study suggest that biologics and small molecule inhibitors (SMIs) do not impair the protective effect of COVID-19 vaccine against hospitalization in patients with psoriasis and ...

A senior Food and Drug Administration official on Friday said the agency will change its vaccine approval process, alleging ...

With no evidence to support the claim that 10 children died due to COVID-19 vaccines, experts unpack the impact of CBER chief ...

The American biotechnology company Novavax announced on Monday that its coronavirus vaccine candidate was found to have an overall efficacy of 90.4% in a Phase 3 trial conducted across the United ...

Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. The recently authorized COVID-19 vaccine developed by Moderna and the National Institute of Allergy ...